Plan's Profile
Displaying 101-150 of 613 result(s).
Go to page:
Recent Articles
- LISCure BioSciences Achieves Milestone with Joint Health Probiotic
- Vantaan Energia Optimizes Energy Solutions with Elisa Gridle
- Tesla Analysts Predict Performance Ahead of Q3 Results
- Renalys Pharma Boosts Alport Syndrome Research Endeavors
- Newly Formed Nominating Committee for SciBase's 2026 Meeting
- Sweco's Groundbreaking Infrastructure Project to Control Flooding
- GBI Partners with Nokia for Enhanced Middle East Connectivity
- Hermès Shows Resilience with Steady Growth in Q3 2025
- Innovative Share Buy-Back by NB Private Equity Partners
- Foresight Group's Strategic Share Buyback Program Highlights
- Eurostar Partnering with Alstom for Next-Gen High-Speed Trains
- Solar A/S Strategically Expands with Sonepar Acquisition
- Boliden's Q3 2025: Exceptional Performance Metrics and Insights
- Boliden Q3 2025 Report: Promising Financial Performance
- Transforming Shanghai into a Leading Global Shipping Hub
- LNG2026 Conference: Key Sessions and Influential Speakers
- All Around Polymer Introduces Innovative Nylon Compounding Framework
- Shelf Intelligence: The Retail Revolution Transforming Shopping
- ACM Biolabs Unveils Promising Safety Data for ACM-CpG Therapy
- Bernie Sanders Critiques Jeff Bezos on Job Automation Push
- General Motors Faces EV Market Challenges Amid Industry Changes
- Beneficient Stock Sees Significant Overnight Growth Catalyst
- Sampo plc Announces Significant Share Buybacks for 2025
- Endeavour Mining's Recent Share Buyback Highlights Strategy
- FLSmidth Announces Successful Share Buy-Back Transactions
- Ringkjøbing Landbobank Provides Strong Q3 2025 Update
- Innovative Collaboration Elevates Electric Powertrain Benchmarking
- Promising Results for Novartis' Cosentyx in PMR Treatment
- Novartis Successfully Completes Hart-Scott-Rodino Waiting Period
- BAWAG Group Reports Strong Q3, Exceeding Performance Goals
- Ipsen Expands Oncology Pipeline with ImCheck Acquisition
- Sanofi's Efdoralprin Alfa: A Breakthrough in AATD Treatment
- Heineken N.V.: Navigating Challenges in Q3 Trading Update
- Borregaard ASA Reports Q3 2025 Results: Strong Agricultural Sales
- Coop Pank Q3 2025: Growth in Customers and Financial Stability
- Heineken Holding N.V. Navigates a Challenging Third Quarter
- Teck Resources Limited Announces Positive Q3 Outcomes
- Ipsen's Sales Surge and Strategic Acquisition Elevate Outlook
- Sanofi's Efdoralprin Alfa Shows Promising Results in Phase 2 Trials
- EfTEN United Property Fund Announces Cash Distribution for 2025
- Ipsen Enhances Oncology Pipeline with ImCheck Acquisition
- Ross Gerber Questions the Value of Elon Musk's Pay Package
- Heineken N.V. Navigates Challenging Market Conditions
- Heineken Holding N.V. Navigation of Q3 2025 Challenges
- Teck Resources Releases Strong Q3 2025 Financial Results
- Ipsen Boosts Financial Guidance Amid Strong Sales Growth
- Aker BP Continues to Impress with Q3 2025 Results
- Ban Ki-moon's Vision for Sustainable Mobility at Chery Group
- Terminus Modern Ballet Theatre Launches Innovative Wabi Sabi Series
- Adlai Nortye's Breakthrough Presentation at Cancer Conference
